1. RETROVIR® (zidovudine) Capsules, syrup, and tablets [package insert]. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20518slr010,19910slr026,19655slr038_retrovir_lbl.pdf [accessed 27.02.14].
2. World Health Organization. New guidance on prevention of mother-to-child transmission of HIV and infant feeding in the context of HIV. Available at: http://www.who.int/hiv/pub/mtct/PMTCTfactsheet/en/ [accessed 01.05.13, last updated 20.7.10].
3. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus–exposed uninfected infants;Williams;JAMA Pediatr,2015
4. Prenatal zidovudine use and congenital anomalies in a medicaid population;Newschaffer;J Acquir Immune Defic Syndr,2000
5. Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000–2009;Tariq;J Acquir Immune Defic Syndr,2011